Cure Rare Disease Secures FDA Orphan Drug Designation for Investigational Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type R9 (LGMD2i/R9)

businesswire

Cure Rare Disease Secures FDA Orphan Drug Designation for Investigational Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type R9 (LGMD2i/R9) – NEWSnet – News… as it used to be

More Press Releases

August 10, 2026

Network Rail and CATALYST Complete Exploratory Pilot of Satellite-Enabled Risk Insights on the Wessex Route

August 10, 2026

Playdigo Strengthens Traffic Quality Across Its Platform Through HUMAN Security Integration

August 10, 2026

Mayor Karen Bass Joins Valley Councilmembers for 13th Annual State of the Valley Luncheon

August 10, 2026

Cure Rare Disease Secures FDA Orphan Drug Designation for Investigational Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type R9 (LGMD2i/R9)

Network Rail and CATALYST Complete Exploratory Pilot of Satellite-Enabled Risk Insights on the Wessex Route

Playdigo Strengthens Traffic Quality Across Its Platform Through HUMAN Security Integration

Mayor Karen Bass Joins Valley Councilmembers for 13th Annual State of the Valley Luncheon

Built for Costa Rica’s Roads: Adobe Rent a Car’s Under-30-Month 4×4 Fleet and Nationwide Airport-Area Coverage